2nd Quarter - Report
LOPER CONSULTING LLC for TEVA PHARMACEUTICALS USA
Firm
Client
Income
$51,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S. 3187 Food and Drug Administration Safety and Innovation Act HR 5651 Food and Drug Administration Reform Act of 2012 drug shortage (HR 2245 and S 296) Supply chain safety (S. 1584)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | special Assistant to the President (2002-2005) |
Labor Issues/Antitrust/Workplace LBR
S. 27 Preserve Access to Generic Drugs; S. 1882 Fair and Immediate Release of Generic Drugs; S. 2295 Patient Safety and Generic Labeling Improvement Act of 2012
| Lobbyist | Covered position, as disclosed |
|---|---|
| GINGER LOPER | Special Assistant to the President (2002-2005) |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.